Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Subclinical ascites defines an intermediate stage between compensated and decompensated cirrhosis.

Zipprich A, Seufferlein T, Dollinger MM.

Z Gastroenterol. 2012 Sep;50(9):996-1001. Epub 2012 Sep 10.

PMID:
22965629
2.

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J; Portal Hypertension Collaborative Group.

Gastroenterology. 2007 Aug;133(2):481-8. Epub 2007 May 21.

PMID:
17681169
3.

Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.

Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM.

Liver Int. 2012 Oct;32(9):1407-14. doi: 10.1111/j.1478-3231.2012.02830.x. Epub 2012 Jun 11.

4.

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27.

PMID:
22532296
5.

Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.

Wang YW, Huo TI, Yang YY, Hou MC, Lee PC, Lin HC, Lee FY, Chi CW, Lee SD.

J Clin Gastroenterol. 2007 Aug;41(7):706-12.

PMID:
17667056
6.

Natural history of compensated viral B and D cirrhosis.

Gheorghe L, Iacob S, Simionov I, Vadan R, Gheorghe C, Iacob R, Parvulescu I, Constantinescu I.

Rom J Gastroenterol. 2005 Dec;14(4):329-35.

7.

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.

Hepatology. 2004 Oct;40(4):802-10.

PMID:
15382176
8.

[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].

Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.

Korean J Hepatol. 2008 Jun;14(2):150-8. doi: 10.3350/kjhep.2008.14.2.150. Korean.

9.

TIPS for management of refractory ascites: response and survival are both unpredictable.

Thuluvath PJ, Bal JS, Mitchell S, Lund G, Venbrux A.

Dig Dis Sci. 2003 Mar;48(3):542-50.

PMID:
12757168
10.

A prognostic model for predicting survival in cirrhosis with ascites.

Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó L, Ventura PJ, Cárdenas A, Guevara M, Sort P, Jiménez W, Bataller R, Arroyo V, Rodés J.

J Hepatol. 2001 Jan;34(1):46-52.

PMID:
11211907
11.

Renal duplex Doppler ultrasound in patients with HCV related liver cirrhosis.

Fouad YM, Mokarrab H, Elgebaly AF, El-Amin H, Abdel-Raheem EM, Sharawy MA, Shatat ME.

Trop Gastroenterol. 2009 Oct-Dec;30(4):213-8.

12.

Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.

Ripoll C, Lastra P, Rincón D, Catalina V, Bañares R.

Scand J Gastroenterol. 2012 Feb;47(2):204-11. doi: 10.3109/00365521.2011.645500.

PMID:
22242615
13.

[MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].

Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.

Vnitr Lek. 2006 Sep;52(9):771-6. Czech.

PMID:
17091599
14.

[Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].

Lee SH, Park SH, Kim GW, Lee WJ, Hong WK, Ryu MS, Park KT, Lee MY, Lee CW, Kim JH, Kim YM, Kim SJ, Baik GH, Kim JB, Kim DJ.

Korean J Hepatol. 2009 Sep;15(3):350-6. doi: 10.3350/kjhep.2009.15.3.350. Korean.

15.

[The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].

Zhang JY, Kuai JH, Jia JD, Wang BE, Qin CY.

Zhonghua Gan Zang Bing Za Zhi. 2009 Apr;17(4):263-5. Chinese.

PMID:
19403023
16.

Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites.

Sersté T, Gustot T, Rautou PE, Francoz C, Njimi H, Durand F, Valla D, Lebrec D, Moreau R.

J Hepatol. 2012 Aug;57(2):274-80. doi: 10.1016/j.jhep.2012.03.018. Epub 2012 Apr 17.

PMID:
22521353
17.

Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.

Pompili M, Rapaccini GL, Covino M, Pignataro G, Caturelli E, Siena DA, Villani MR, Cedrone A, Gasbarrini G.

Cancer. 2001 Jul 1;92(1):126-35.

PMID:
11443618
18.

High prevalence of normal serum albumin in NASH patients with ascites: a retrospective analysis.

Sourianarayanane A, O'Shea RS, Barnes DS, McCullough AJ.

Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):246-53. doi: 10.1016/j.clinre.2012.10.006. Epub 2012 Nov 22.

PMID:
23177511
19.

[Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].

Zhang JY, Qin CY, Jia JD, Wang BE.

Zhonghua Gan Zang Bing Za Zhi. 2012 Feb;20(2):108-11. doi: 10.3760/cma.j.issn.1007-3418.2012.02.008. Chinese.

PMID:
22464781
20.

Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.

Ripoll C, Bañares R, Rincón D, Catalina MV, Lo Iacono O, Salcedo M, Clemente G, Núñez O, Matilla A, Molinero LM.

Hepatology. 2005 Oct;42(4):793-801.

PMID:
16175621
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk